MITF and melanoma: Although it remains unclear if or how deregulated MAPK signaling might enable MITF to differentiate between its targets implicated in proliferation versus those driving differentiation, understanding how MITF activity is regulated is especially important in melanoma as varying MITF activity has been associated with drug and immunotherapy resistance14–17,36–40.